Sponsor

IlDong Pharmaceutical Co Ltd

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name IlDong Pharmaceutical Co Ltd appears in 12 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials12
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

12 shown
To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult VolunteersNCT05259020 · lead sponsor · 2022-02-22
UNKNOWN
IDG-16177 for the Evaluation of Its Safety and PharmacokineticsNCT04982705 · lead sponsor · 2021-07-07
UNKNOWN
To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male AdultsNCT04185090 · lead sponsor · 2020-02-01
UNKNOWN
A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab.NCT03648801 · lead sponsor · 2018-09-01
UNKNOWN
A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus.NCT03655288 · lead sponsor · 2017-07-25
UNKNOWN
Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's DiseaseNCT03363269 · lead sponsor · 2016-04-12
COMPLETED
Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With HyperlipidemiaNCT03566316 · lead sponsor · 2015-11-24
COMPLETED
Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and EfficacyNCT03742544 · lead sponsor · 2015-06-23
UNKNOWN
Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension PatientsNCT02738632 · lead sponsor · 2015-05-01
COMPLETED
A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and ValsartanNCT02343250 · lead sponsor · 2015-03-01
COMPLETED
Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With HypertensionNCT02145104 · lead sponsor · 2014-06-17
COMPLETED
Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With HyperlipidemiaNCT02087540 · lead sponsor · 2013-05-01
UNKNOWN

Drugs studied in this sponsor's trials

2 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing IlDong Pharmaceutical Co Ltd as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
rosuvastatin1
telmisartan1

Sponsor roles

lead sponsor12
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.